Confirmed Exhibitors

Exhibit & Sponsorship Opportunities
Confirmed Partners
Confirmed Exhibitors
Exhibitors Manual

WTC 2025 Exhibitors

WTC 2025 Congress offers a unique opportunity to market to an international multidisciplinary event of researchers, clinicians, health professionals and patient advocates in the field of research and management.

WTC 2025 Organizing Committee would like to thank all our exhibitors for their support:

As the oldest and largest, independent kidney patient organization in the U.S. AAKP is dedicated to improving the lives and long-term outcomes of kidney patients through education, advocacy, patient engagement, and the fostering of patient communities. AAKP fights for early disease detection and the appropriate diagnosis of rare/genetic conditions. Pleximark blood test measures the likelihood of acute cellular rejection by measuring whether recipient lymphocytes called T-cytotoxic memory cells show increased anti-donor activity PlexCMV measures the level of cellular immunity to Cytomegalovirus (CMV) to help formulate personalized antiviral therapy or immunosuppressive treatment. Establishing the level of anti-EBV immunity at baseline and during periods of high dose immunosuppression permits the level of anti-EBV immunity to be assessed in each patient allowing for adequate treatment planification.

The American Board for Transplant Certification (ABTC®) promotes education, competency, and professional growth in organ transplantation through exclusive, specialty certifications. ABTC certification programs include Certified Clinical Transplant Coordinator (CCTC®) Certified Clinical Transplant Nurse (CCTN®) Certified Procurement Transplant Coordinator (CPTC®) Certified Transplant Preservationist (CTP®) and Certified Transplant Financial Coordinator (CTFC).

Associates of Cape Cod, Inc., manufactures Fungitell® and the single patient sample format, Fungitell STAT® Assay. The Fungitell product line is the Gold Standard in Rapid Screening for Invasive Fungal Infection (IFI) and is the first and only FDA-cleared & CE marked rapid in vitro diagnostic screening test for IFI (including Candida, Aspergillus & Pneumocystis) that detects (1→3)-ß-D-Glucan in serum.

Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for more than 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on hematology, nephrology, neurology, metabolic disorders, cardiology and ophthalmology. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in 70 countries. For more information, please visit www.alexion.com.

ALS engineers innovative and agile protective solutions targeting the key molecular pathways implicated in IRI. By protecting organs from IRI, ALS optimizes graft function recovery throughout the transplantation journey thereby improving patients’ survival and outcomes.

At Apellis, we combine courageous science and compassion to develop life-changing medicines for some of the most challenging diseases patients face. Our goal is to transform treatment for a broad range of debilitating diseases by controlling a part of the immune system known as the complement cascade. We ushered in the first new class of complement medicine in 15 years, and now have two approved medicines targeting C3, the central protein in the cascade. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases.

Baskent University was founded in 1993, as one of the foundation universities of Turkey. The founder and honarary president, Prof. Dr. Mehmet Haberal, performed the first successful transplantation surgery in Turkey (1975) and is renowned worldwide in the medical community.

Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world. Founded in 1978, Biogen has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease.

BIOHOPE is a leading biotechnology company specializing in personalized medical solutions for chronic inflammatory conditions. Our IMMUNOBIOGRAM is the world’s first non-invasive, personalized in-vitro diagnostic that assesses kidney transplant patients’ responses to immunosuppressants, empowering doctors to optimize treatment strategies, reduce rejection risks, and minimize adverse effects, improving patient outcomes.

Bridge to Life Ltd is a market leader in organ preservation solutions, offering premier products such as Belzer UW®, EasiSlush® and the VitaSmart Hypothermic Oxygenated Perfusion System. With a strong focus on product quality, innovation and accessibility, the company serves and partners with leading Transplant Centers and Organ Procurement Offices globally.

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook and Instagram.

CareDx, Inc., based out of Brisbane, California, is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions.

CTI Clinical Trial and Consulting, a global leader in research services, provides support across the clinical development lifecycle. With unmatched expertise in transplantation, CTI has contributed to nearly all transplant-related therapies, from organ preservation to post-transplant care. In its third decade, CTI ranks among the top 20 CROs.

See the Visible Difference® with Designs for Vision’s exclusive wearable fluorescence wound imaging solution: REVEAL FC. Designs for Vision has been innovating wearable visual enhancement solutions for clinicians since 1961. Visit our booth to see our many magnification and illumination solutions including our patented Panoramic Loupes. Panoramic Loupes provide unprecedented field of view (100% wider than Prismatic Loupes). The LED DayLite° HDi headlights utilize exclusive optical designs that provide 45% brighter illumination with even distribution.

Diatiro is rethinking transplantation with human-centered design and biodesign-driven innovation. The KidneyPod™ creates a stable 4°C (39°F) microclimate around the kidney during anastomosis, using phase-change technology and aerospace-grade insulation to protect the organ when it matters most. Built by surgeons, for surgeons, it’s precise, efficient, and seamless.

Donor Network West is a federally designated nonprofit 501(c)3 Organ Procurement Organization (OPO) with headquarters in northern California and northern Nevada. Our organization is committed to helping save and heal lives, supporting donor families and developing organ donation as a fundamental human responsibility.

Eledon is dedicated to significantly improve both the longevity of the organ and the overall health and quality of life for transplant recipients. Our lead compound is tegoprubart, an anti-CD40L antibody with broad therapeutic potential to regulate drivers that can lead to the immune system attacking and rejecting transplanted organs.

From pre-transplant protocols and screening to post-transplant diagnostics and rejection monitoring, the journey is perpetual. Enhancing patient outcomes necessitates the utilization of cutting-edge technology throughout every step of the patient’s path. This is where Eurofins Transplant excels. Eurofins Transplant revolutionizes transplant testing, offering breakthrough solutions that empower both patients and providers alike. Comprising five key divisions within Eurofins: Cell TX, Donor & Product Testing, Ascend Clinical, Viracor, and Transplant Genomics, these organizations collectively influence every critical stage in the transplant journey.

GEISTER MEDIZINTECHNIK GMBH - founded in 1984 - is a manufacturer and system supplier of surgical instruments for conventional open and minimal invasive (keyhole) surgery with a focus on cardiovascular, neuro-, joint and powered surgery. Located in Tuttlingen in Southwest Germany - the famous capital of the surgical industry worldwide. We are dedicated to servicing and supplying the surgical world with the highest quality instruments according to the specific requirements and helping medical professionals with their patient care in every part of the world.

From its formation in 2015, GTS has focused on improving the quality of preservation solutions, worldwide, by partnering with a 100 year+, FDA, EU, and Health Canada certified sterile solution manufacturer, SALF, of Bergamo, Italy. GTS and SALF work together relentlessly to improve the useability, storage, and overall quality of every solution produced at SALF. One example; GTS has researched methods of shipping/storage, which resulted in the first, 100% recyclable shipping container system for preservation solutions delivered to the Global organ procurement community. This focus on “Total Quality” turned out to be very fortuitous, in that since GTS’s first FDA clearance in the US (Servator H – HTK in 2017), several other suppliers of organ preservation solutions have had their products, FDA/EU withdrawn due to contamination and other quality issues.

At Gold Standard Preservation, we are dedicated to maximizing organ viability to extend life-saving opportunities. We strive to add unparalleled value to the organ transplantation community-believing that every organ allows the donor's story to continue and lets donor families know their loved ones are remembered.

IGL specializes in medical technology for donor organ and tissue preservation. Founded by Georges Antoine Lopez, inspired by his father's transplants, IGL is devoted to creating safe, innovative solutions that ensure transplantation success and enhance patient quality of life. Decades of research and expertise define IGL's trusted reputation.

IIAM is at the forefront of providing non-transplantable organs to the medical research community for purposes of combatting and curing disease. IIAM has collaborations to source organs and other human tissue for medical studies, therapeutic applications and pre-clinical investigations targeting a range of debilitating disorders.

From our award-winning international iTransplant® Platform facilitating critical organ donation activity and providing transplant programs next-generation solutions, to our iReferral® interfaces automating the key donor referral process, and our iTx App enabling speed across the donation-transplant ecosystem, InVita is proud to enable the work of donation and transplantation heroes.

Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. The company’s proprietary INVYMAB™ platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to address evolving viral threats. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb in a planned series of innovative antibody candidates. Visit https://invivyd.com/ to learn more. X: https://x.com/invivyd LinkedIn: Invivyd | LinkedIn

The Iron Intern® Stieber Rib Grip is an open retraction system for liver transplant that provides superior exposure for the precise and safe removal of organs with total ease of set up and extreme flexibility. It is used in many prominent transplant centers, and achieves the strongest and safest exposure.

Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The company’s Specialty Brands reportable segment’s areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; and gastrointestinal products. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients. To learn more about Mallinckrodt, visit www.mallinckrodt.com.

MedSleuth is transforming the way patients participate in their healthcare. MedSleuth allows patients to easily provide those portions of their medical histories most relevant for a given episode of care. We invite you to take a deeper look and see how this could help you!

Melinta Therapeutics provides innovative therapies to people impacted by acute and life-threatening illnesses. With an unsurpassed commitment to providers and the patients they serve, we work to ensure that all people who need our therapies can receive them. At Melinta, we’re visionaries dedicated to innovation while staying grounded in what matters most: patients.

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.

MiraVista Diagnostics is a specialty diagnostic laboratory and device manufacturer committed to improved patient outcomes by developing highly accurate test solutions for the diagnosis and treatment of serious fungal infections. MiraVista specializes in testing for histoplasmosis, coccidioidomycosis, blastomycosis, aspergillosis, pneumocystis and (1–3)-β-D glucan by offering antigen, antibody, and PCR testing.

At MN24, we Transport Second Chances by specializing in seamless air and ground logistics support tailored specifically for organ transport needs. With our dedicated teams, we’re focused solely on ensuring that organs and transplant teams reach their destinations on time, safely, and efficiently. We are not brokers. We operate with full-time, salaried staff, including drivers, pilots, and dispatchers, all devoted to transplant logistics. Our team operates Code 3 vehicles and works closely with transplant centers, Organ Procurement Organizations (OPOs), and organ preservation device companies. We understand that time is everything in this field, and our priority is to eliminate delays, significantly lower costs, and, most importantly, save lives.

Natera provides advanced DNA technology that enables transplant providers to deliver quality, personalized care. As a diagnostics company with proprietary bioinformatics and molecular technology, we’ve performed more than 10 million cfDNA tests and are dedicated to improving kidney, heart and lung care for good. Learn more at natera.com/organ-health.

Nebraska Medicine's world-renowned transplant program provides comprehensive treatment for diseases that affect the liver, intestine, kidney, pancreas, heart and lung. We also offer care for pediatric liver transplant, pediatric kidney transplant and pediatric intestinal transplant patients. Through dedicated efforts in education and research, and innovations in clinical medicine, we help shape the field of transplantation every day.

NORA (Nationwide Organ Recovery Transport Alliance) works with OPOs, Transplant Centers and other recovery partners throughout the country to provide the perfect “One Call Solution” for Air and Ground Organ Recovery Transportation. Efficiency, attention to detail, understanding critical time management, budget constraints and the importance your program plays in the community make NORA the perfect addition to the Organ Donation, Procurement and Transplantation processes.

Northernmost (Edmonton, Alberta, Canada) is developing a new kidney pump.

OrganOx is at the forefront of changing the way donor organs are preserved in the critical time between donation and transplantation. Our leading product, the metra®, harnesses patented normothermic machine perfusion technology to preserve donor livers prior to transplant.

From the success of LifePort Kidney Transporter, Organ Recovery Systems introduces the next generation of preservation with the upcoming launch of the LifePort Liver Transporter. In addition to providing innovative products, ORS delivers support via the LifePort mobile app, 24/7 Perfusion Helpline, Instructor-Led Training, and online Client Community.

Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to preservation that represents a significant improvement over the traditional standard of care. Paragonix Advanced Organ Preservation devices combine clinically-proven, stable cooling techniques with digital tracking and monitoring technologies to provide clinicians complete control and oversight throughout the donor organ journey. The clinical impact of Paragonix preservation technology is reinforced by the GUARDIAN clinical registries, the largest database of organ preservation data in the world that analyzes post-transplant outcomes in transplant recipients.

Pleximmune measures the risk of acute cellular rejection after liver or intestine transplantation in children and young adults less than 21 years of age. FDA-approved blood test Pleximark blood test measures the likelihood of acute cellular rejection by measuring whether recipient lymphocytes called T-cytotoxic memory cells show increased anti-donor activity PlexCMV measures the level of cellular immunity to Cytomegalovirus (CMV) to help formulate personalized antiviral therapy or immunosuppressive treatment. Establishing the level of anti-EBV immunity at baseline and during periods of high dose immunosuppression permits the level of anti-EBV immunity to be assessed in each patient allowing for adequate treatment planification.

ProCure On-Demand offers the transplant community the highest quality organ recovery services in a reliable, flexible model with favorable pricing. ProCure offers an improved model for engaging more best-in-class surgeons and clinicians in the organ recovery process, flexibility to choose when and how you need support, optimized logistical strategies and transportation solutions that save time and money.

QuidelOrtho provides high quality solutions to monitor transplant autoimmune response, specifically the complement system. Our products include ELISA kits, antibodies, proteins, sera, and reagents, and can be used to monitor complement system activation.

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.

The Advanced Organ Therapies Program at Sutter Health CPMC provides cutting-edge treatments for individuals facing advanced heart, liver, kidney, and pancreas conditions. By integrating innovative technologies, emphasizing metabolic health, and implementing transitional care strategies, the program delivers comprehensive care for those in need of organ transplantation.

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. www.takeda.com

Tampa General Hospital’s Transplant Institute is ranked #1 in the nation for transplant volume, performing 889 transplants in 2024. The institute excels in managing complex cases and pioneering innovative technologies. With a focus on quality, efficiency, and lives saved, it continues to set new standards in transplant care. www.tgh.org/institutes-and-services/transplant-institute

The Alliance unites the organ donation, transplantation and healthcare community to promote collaboration, cascade innovations and share effective practices for the benefit of restoring lives through transplantation. www.organdonationalliance.org

TransMedics is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. We developed the Organ Care System, or the OCS, to replace a decades-old standard of care that we believe is significantly limiting access to life-saving transplant therapy for hundreds of thousands of patients worldwide. Our innovative OCS technology replicates many aspects of the organ’s natural living and functioning environment outside of the human body. As such, the OCS represents a paradigm shift that transforms organ preservation for transplantation from a static state to a dynamic environment that enables new capabilities, including organ optimization and assessment. www.transmedics.com

Trinity Medical Solutions (Trinity), a BLADE Urban Air Mobility Company is solely focused on reducing the organ shortage with comprehensive solutions supporting Transplant Programs, Organ Procurement Organizations, and industry partners around the country with the ability to recover and transplant as many organs as possible. www.trinityairmedical.com

Valiant AI leverages artificial intelligence and machine learning to address the organ donor shortage, revolutionizing kidney transplantation. By analyzing vast data, their innovative solutions optimize donor-recipient matching, predict organ viability, and enhance transplant success rates, eliminating delays and improving patient outcomes in healthcare. www.valiantai.co

Verici Dx is a trusted partner in kidney transplant care, offering AI powered RNA signatures through Tutivia. Tutivia is an assay that provides actionable risk scores supporting clinical decision-making in kidney transplant care. We're dedicated to advancing transplant science and making a positive impact on patients' lives. www.vericidx.com

Veloxis Pharmaceuticals, Inc., an Asahi Kasei company, is a fully integrated specialty pharmaceutical company committed to improving the lives of transplant patients. Headquartered in Cary, North Carolina, USA, Veloxis is focused on the global development and commercialization of medications utilized by transplant patients and by patients with serious related diseases. For further information, please visit www.veloxis.com

Werfen is a growing, family-owned, innovative company founded in 1966 in Barcelona, Spain. We are a worldwide leader in specialized diagnostics in the areas of Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplant. Through our Original Equipment Manufacturing (OEM) business line, we research, develop, and manufacture customized assays and biomaterials. www.werfen.com/en

Founded in 1998, XVIVO is the only MedTech company dedicated to extending the life of all major organs – so transplant teams around the world can save more lives. XVIVO’s innovative technologies enable clinicians and researchers around the world to preserve, transport and assess organs outside the body. Our pioneering technologies have been clinically proven to increase utilization of donated organs and improve transplantation outcomes. www.xvivogroup.com

Confirmed Exhibitors

WTC 2025 Exhibitors

WTC 2025 Organizing Committee would like to thank all our exhibitors for their support:

Useful Links

Stay Connected!

Contact Us